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Background: Over the past decade, the treatment of popliteal aneurysms has evolved at our institution from sole operative
intervention during the initial part of the study period, to combined surgical and endovascular treatment, and ﬁnally to
endovascular-centered management in more recent years.
Methods: This is a retrospective review of all patients with popliteal aneurysms treated at our institution from 2001 to
2011. Data collection included the indication for intervention, treatment details, interventional patency, limb salvage,
perioperative outcome, and midterm survival.
Results: Eighty-eight aneurysms (72 patients) were treated during this period. Indications for intervention included
symptomatic presentations in 53% (n [ 47) and asymptomatic in 47% (n [ 41). Treatment included endovascular
exclusion in 24, surgical repair in 63 (14 posterior approach and 49 medial approach with bypass and exclusion), and
primary amputation in one patient. Nine aneurysms (10.2%) received catheter-directed thrombolysis. Demographics were
similar between the two treatment cohorts, except for age with endovascular stenting patients being signiﬁcantly older
(76.0 vs 66.0 years; P [ .002). The mean length of stay was 3.9 days vs 9.5 days (P < .001), favoring endovascular
treatment. There were no perioperative (30-day) deaths in the endovascular group and one in the surgical cohort. The
mean patency follow-up was 21.2 vs 28.3 months. Primary patency did not differ between endovascular and surgically
treated patients at 1 year (92.9% vs 83.3%; P [ .26) and 3 years (63.7% vs 77.8%; P [ .93). No limbs were lost in the
endovascular group during the follow-up period of 22.4 months, and one late limb loss occurred in the surgical cohort
(mean follow-up, 29.2 months). Endovascular patients had a midterm survival rate of 65% (mean follow-up,
33.9 months), whereas surgical patients experienced a survival rate of 80.8% (mean follow-up, 42.9 months; P [ .22).
Conclusions: Endovascular treatment of popliteal aneurysms provides similar short-term patency to that of the traditional
gold standard approach with surgical bypass, with shorter hospitalizations in both symptomatic and asymptomatic
patients. Further long-term follow-up is required to compare these two treatment modalities for durability to determine
the optimal popliteal aneurysm management. (J Vasc Surg 2013;57:1306-10.)There are two main treatment modalities for popliteal outcomes of PAA repair using the posterior approach, the
artery aneurysms (PAAs): (1) surgical repair by either exclu-
sion and bypass/resection with interposition, and (2) endo-
vascular treatment. Since 1969, proximal and distal ligation
of the popliteal artery and bypass grafting via the medial
approach have been the gold standard treatment of both
symptomatic and asymptomatic PAAs.1 Although the
medial approach has good long-term durability, continued
aneurysm growth occurs in some patients as well as the
expected morbidity from infrainguinal reconstructions.2-7
In addition, the lack of a saphenous vein can be problematic
in some patients. Surgical treatment for PAAs via the poste-
rior approach has become a more popular treatment option
in the past few decades. However, at this point, little is
known about the results of this type of approach. In a recent,
noncontrolled case series that reported early and midtermthe Department of Vascular Surgery, West Virginia University.
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6patency rate at 2 years was 92.2%.5
Since the ﬁrst stenting of a popliteal artery in 1994,
endovascular intervention for PAAs has become an attrac-
tive alternative to open repair. The endovascular exclusion
of PAAs offers many potential advantages, including the
use of a local anesthetic only, decreased blood loss, quicker
recovery, and shorter hospital stay. Early results have also
shown decreased morbidity and mortality in electively
repaired asymptomatic PAAs.6,8,9 The main concern with
PAA endovascular exclusion is the limited data regarding
long-term durability. Unlike endovascular treatment of
abdominal aortic aneurysms, determination of stent graft
candidacy has not been ﬁrmly established.6,8,9
Most of the work on peripheral aneurysms focuses on
the open repair of PAAs, mainly using the medial surgical
approach. Recommendations regarding the modality of
treatment for PAAs are limited to the small number of
patients in most studies and the preference for open repair
via the medial approach. The aim of this retrospective study
was to compare the two main types of treatment for PAAs,
open/surgery and endovascular interventions, and to
deﬁne the midterm outcomes of these treatment tech-
niques on both symptomatic and asymptomatic patients.
METHODS
All patients who were treated using either endovascular
or surgical methods (including amputation) for PAAs at
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and 2011 were reviewed retrospectively. Four vascular
interventionists, four vascular surgeons, and ﬁve cardiotho-
racic/general surgeons preformed procedures on patients
included in the study. The CAMC Institutional Review
Board approved the study design and protocol. A list of
patients admitted at CAMC with a PAA during the study
time period was generated from CAMC’s data warehouse
using the International Classiﬁcation of Diseases, Ninth
Revision (ICD-9) code of 442.3 (other aneurysms of artery
of lower extremity). As that ICD-9 diagnosis code is used
for other lower limb aneurysms besides the popliteal artery,
electronic medical reocrd/Soarian records of patients with
the ICD-9 code of 442.3 were reviewed to determine the
type of lower limb aneurysm. Patients over the age of 18
with PAAs were included in the study and their data
were collected.
During the study, patient records were evaluated for
patient demographics, procedural details, patency rate,
need for secondary intervention, amputation-free survival,
and overall survival. During the study, patients were either
deﬁned as symptomatic or asymptomatic. Symptomatic
patients were deﬁned as those with acute ischemia: throm-
botic or embolic, venous compression, or with claudication
attributed to the PAA. Patients who were asymptomatic
received endovascular or surgical intervention if their aneu-
rysms were 2.0 cm or larger. Asymptomatic patients with
smaller aneurysms were treated if mural thrombosis was
present. The number of runoff vessels determined by tibial
vessels in continuity with the pedal arteries was recorded
from angiography when available, and the aneurysm diam-
eter was also recorded.
For patients who underwent endovascular procedures,
the approach of the procedure (either percutaneous or cut-
down) and the type of access route (ipsilateral or contralat-
eral) were recorded. The number of stent grafts (Viabahn;
W. L. Gore and Associates, Flagstaff, Ariz) needed and
the size of all of the stents used were obtained. For patients
who underwent surgical procedures, the approach, either
medial or posterior, was noted as well as the inﬂow and
outﬂow vessels used for the proximal and distal anastamosis.
The conduit was also recorded (ie, saphenous vein or poly-
tetraﬂuoroethylene). If catheter-directed thrombolysis was
performed as adjunct therapy to either an endovascular or
surgical PAA intervention, it was performed in the endovas-
cular suite using the pulse-spray technique with Activase
(alteplase) 0.5 to 1.0 mg/kg/hr and serial angiography at
every 6 to 8 hours. Catheter-directed thrombolysis was
not performed in the operating suite. For both types of
procedures, the patient’s medications at discharge, perio-
perative (30-day) complications, and imaging results from
duplex, computed tomography, or angiography were ob-
tained and analyzed to determine the interventional
patency. Limb loss follow-up included date of last evalua-
tion at our institution and survival by the social security
database. Therefore, three time intervals were measured
during the follow-up: interventional primary patency, limb
salvage, and survival. Primary graft patency (unassisted)was deﬁned as uninterrupted patency of the conduit by
duplex ultrasound or conventional contrast angiography.
Postoperative color duplex ultrasound and other imaging
of the popliteal artery were used as an indicator of patency.
Unfortunately, patient follow-up practices after the proce-
dure were different among clinician groups, with most of
the nonvascular surgeons not having regularly established
follow-up schedules. Our vascular practice advocates
patients follow-up with color duplex ultrasound at 1 and
6 months and then every 12 months postprocedure;
however, patient and clinician compliance is imperfect.
Statistical analysis. The data analysis was performed
using IBM SPSS Statistics 19.0 (SPSS Inc, Chicago, Ill).
Basic descriptive statistics, such as means and SDs for
continuous variables and proportions and frequencies for
categorical variables, were used to analyze patient, proce-
dures, and outcome characteristics. Rates of patency were
analyzed using the Kaplan-Meier method with log-rank
tests to compare groups. Values between endovascular
and surgical procedures were compared by the t-test for
continuous variables and the c2test. A P level of <.05 was
used to determine statistical signiﬁcance.
RESULTS
Patient data. In a consecutive cohort of patients,
88 limbs in 72 patients underwent intervention for PAAs.
The demographics and indications for intervention and
interventional results are listed either as endovascular or
surgical (Table). Fig 1 demonstrates the evolution of
treatment at our institution over the past decade.
Endovascular intervention. Endovascular interven-
tion was performed on 24 PAAs in 20 patients (19 male;
median age, 76.2 6 9.1 years; range, 50-92). Three
(15.0%) of these patients were active smokers, 11 (55.0%)
were past smokers, and six (30.0%) were nonsmokers. Nine
patients (45.0%) had coronary artery disease, four patients
(20.0%) had a history of myocardial infarction, 15 patients
(75.0%) had hypertension, and 12 patients (60.0%) had
hyperlipidemia. Seven patients (35.0%) had a history of an
aneurysm of the abdominal aorta and eight patients
(40.0%) had a history of bilateral PAAs. The mean diameter
of 24 of the PAAs was 2.9 6 1.5 cm (range, 1.5-7.0).
Indications for intervention. For patients who under-
went endovascular treatment for PAAs, 17 were elective and
seven were urgent/emergent. Eleven of the patients were
symptomatic, whereas 13 were considered asymptomatic.
Of the 11 patients considered symptomatic, four patients
had acute limb ischemia and seven had claudication. Three
patients underwent thrombolysis before their endovascular
procedures and one patient had a ruptured aneurysm with
distal popliteal occlusion and was treated with embolization
of the proximal popliteal artery only.
Procedural details. Of all 24 PAAs treated with endo-
vascular repair, the approach was an antegrade cutdown ipsi-
laterally for ﬁve PAAs (20.8%), percutaneous retrograde
contralaterally in eight PAAs (33.3%), and percutaneous
antegrade ipsilaterally in 11 PAAs (45.8%). Of the 24 limb
PAAs, one PAA (4.2%) was treated with coil embolization
Fig 1. A time course of methods employed for popliteal artery
aneurysm (PAA) management.








Age 76 6 9.80 65.96 6 12.56 .002
Sex
Male 19 (95.0%) 52 (100%) .28
Race
Caucasian 20 (100%) 52 (100%) ....
Comorbidities
History of bilateral PAA 8 (40.0%) 29 (55.8%) .35
Coronary artery disease 9 (45.0%) 21 (40.4%) .93
History of abdominal aorta
aneurysm
7 (35.0%) 20 (38.5%) 1.00
History of myocardial
infarction
4 (20.0%) 7 (13.5%) .48
Hypertension 15 (75.0%) 33 (63.5%) .41
Hyperlipidemia 12 (60.0%) 32 (61.5%) 1.00
Tobacco use
Active smokers 3 (15.0%) 16 (30.8%) .32
Past smokers 11 (55.0%) 20 (38.5%)
Nonsmokers 6 (30.0%) 16 (30.8%)
PAA, Popliteal artery aneurysm.
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six PAAs (25.0%) had two stent grafts placed, four PAAs
(16.6%) had three stent grafts placed, and two PAAs (8.3%)
had four stent grafts placed. The average total length of stent
grafts was 18.76 11.3 cm (range, 2.5-40). Stent grafts were
placed with smallest to largest diameter, if more than one
stent graft was required, with a minimum of 10 mm overlap
and 10 mm seal zone, both proximally and distally.
Complications and follow-up. Length of stay varied
based on the urgency of the procedure with 3.4 6 2.4 days
for elective and 5.0 6 3.6 for emergency procedures, with
an overall mean length of stay of 3.9 days. One patient had
a groin hematoma at the access site, >6 cm but did not
require operative therapy. In the endovascular-treated
cohort, two patients died prior to receiving imaging for vessel
patency determination. According to follow-up data, four ofthe 23 PAA stents failed, and all of the failures were due to
occlusion. No patients were found to have an endoleak on
follow-up ultrasound imaging. Four patients had stent graft
occlusion during the follow-up period ranging from 5 to
25 months. Two of the failures involved reintervention, one
by angioplasty and stent placement after catheter-directed
thrombolysis and the other by surgical bypass. Two
patients were managed medically with claudication symp-
toms only. No patients required a major amputation during
the follow-up period.Of the late failures, three out of the four
patients had more than one stent graft placed. Primary
patency at 1 and 3 years was 92.9% and 63.7%, respectively.
Seven of the 20 patients died during the follow-up.
The loss of limb follow-up mean was 22.4 months (range,
0-105 months) and one of the 24 limbs required only toe
amputations secondary to an embolic event at the time of
presentation. The mean follow-up period was 33.9 months
(range, 2-105 months) for midterm survival.
Surgical intervention. Surgical procedures were per-
formed for 64 PAAs in 52 patients (all male; median age,
65.956 12.56 years; range, 32-85). Sixteen (30.8%) of these
patients were active smokers, 20 (38%) were past smokers,
and 16 (31%) were nonsmokers. Twenty-one patients
(40.1%) had coronary artery disease, seven patients (13.5%)
had a history of myocardial infarction, 33 patients (63.5%)
had hypertension, and 32 patients (61.5%) had hyperlipid-
emia. Twenty patients (38.5%) had a history of an aneurysm
of the abdominal aorta and 29 patients (55.8%) had a history
of bilateral PAAs. The mean diameter of 53 of the PAAs was
3.0 6 1.1 cm (range, 1.5-5.8).
Procedural details. Of the 64 open surgical procedures
performed for PAAs, one of the procedures was an amputa-
tion and 63 were surgical bypasses. Forty-four of the
procedures were elective and 20 were emergent. Thirty-six
patients were symptomatic while 28 were asymptomatic.
Of the 36 symptomatic patients, 18 had acute limb ischemia,
10 had claudication, three had venous compression, and ﬁve
had embolic presentation. Six patients underwent throm-
bolysis before their surgical procedures, and no patients had
ruptured aneurysms. Of the surgical procedures, 49 were
approached medially and 14 were approached posteriorly.
Posterior approach procedures were predominantly per-
formed by a single vascular surgeon who routinely uses this
approach as his primarily method as long as the PAA begins
below the adductor canal. The posterior approach was
additionally utilized by other vascular surgeons if the patient
lacked an ipsilateral saphenous vein or possessed a large
aneurysm with compressive symptoms. Proximal and distal
ligation was routinely performed in medial approach bypass
surgeries. Surgeries using the posterior approach employed
ligation of back bleeding side branches and end-to-end
interposition grafting. Conduits used included saphenous
vein for 41 limbs, 20 PTFE, one used the basilic vein, and
one used a Dacron graft.
Complications and follow-up. Length of stay varied
depending on indication: 7.3 6 4.7 days for elective and
14.0 6 9.6 days for emergent procedures, with an overall
mean of 9.5 days, signiﬁcantly longer than the endovascular
Fig 2. Kaplan-Meier curve of primary patency rates.
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and two patients had hematomas as perioperative complica-
tions. Eight patients developed wound infections, four
patients had amputations after reconstruction for irreversible
ischemia, despite patent bypasses. Two patients had enlarge-
ment of their aneurysms during late follow-up requiring
surgical decompression. According to the follow-up data,
there were 13 graft failures of 63 PAAs. One patient had late
limb loss secondary to bypass failure, one patient had open
bypass revision within the postoperative period for early graft
thrombosis, three patients had endovascular interventions
for duplex-detected stenosis, and four patients had graft
thrombosis without limb loss and no secondary intervention.
In the surgical intervention cohort, 11 patients (eight in the
medial and three in the posterior approach) were lost to
follow-up prior to patency determination. Primary patency at
1 and 3 years was 83.3% and 77.8%, respectively. Fig 2
compares primary patency in the two PAA treatment
modalities (endovascular vs surgical).
The mean follow-up for limb salvage was 29.2 months
(range, 0-116 months) and six of the 64 (9.2%) limbs had
amputation. The mean follow-up period was 42.9 months
(range, 1-122 months) for all-cause mortality. Ten of the
52 patients (19.2%) died during follow-up (at a mean of 43
months; range, 1-122 months).
DISCUSSION
Treatment of PAAs has changed over the past decade at
our institution. During the ﬁrst 5 years of the study period,
only exclusion and bypass procedures were performed in
cases of either acute limb ischemia or in elective cases. Thistreatment strategy has been the gold standard treatment
with which all other modalities have been compared. In
contrast, during the later half of our study period, the poste-
rior open approach and endovascular adjuncts for treatment
(ie, catheter-directed thrombolysis and stent grafting were
employed).
Endovascular management with stent grafting for
abdominal aortic aneurysms has replaced surgical repair in
our institution as well as many other institutions as the ﬁrst
line of treatment for patients who are candidates. For
PAAs, there is no level 1 evidence to support changing the
treatment from the gold standard (exclusion and bypass).
Obviously, with the decreasing delivery system size, a total
percutaneous approach offers the potential for shorter
hospital stays and lower perioperative morbidity. Initially,
in our experience, antegrade approaches were performed
with cutdowns to close an often 9 ormore F sheath site. Since
most stent grafts can now be deployed with an 8F or less, an
ipsilateral antegrade or contralateral approach is safe. The
decreased length of stay between the two groups (endovas-
cular vs surgical) was statistically signiﬁcant, with most of
our patients going home the day after their procedure.
Therefore, if perioperative morbidity can be minimized
with endovascular techniques, including shorter length of
stay, minimal infection risk, and early return to activities,
then durability is the major hurdle for more widespread use
of this technology. Unfortunately, our follow-up was short
with a mean patency data by duplex examination of only
18 months; however, other authorities have reported satis-
factory results after long-term follow-up. Jung et al10
reported an 84% patency rate and 100% secondary patency
rate and provided one of the longest mean follow-up
periods of 54 months. This is also similar to a larger series
by Tielliu et al9 who reported on 73 limbs with primary
and secondary patency rates at 5 years of 70% and 76%,
respectively. Regrettably at our institution, patient follow-
up practices after procedure differ among clinician groups,
with a majority of the nonvascular surgeons not having
standardized follow-up schedules. Our vascular practice
advocates patients to follow-up with color duplex ultrasound
at 1 and 6 months and then every 12months postprocedure;
however, patient and clinician compliance is imperfect.
We had four stent graft occlusions in 23 limbs during
follow-up ranging from 5 to 25 months. Although 17% of
limbs receiving stents had failures, only two required reinter-
ventions. More importantly, no patient experienced limb
loss. One patient was asymptomatic and was found on
routine duplex examination, one patient developed claudica-
tion with occlusion, and two presented with acute limb
ischemia: one treated by endovascular methods, whereas
the other one underwent bypass. No limbs were lost in the
follow-up period. In addition to patency issues, endoleaks
or persistent aneurysm growth can occur with either exclu-
sion and bypass (the gold standard) or with stent grafting.
We had no endoleaks in our series and no conversions to
open surgery for enlarging aneurysms, despite patent stent
grafts. We did have three patients in the surgical group
who required treatment for symptomatic aneurysm sac
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of the posterior approach that is appealing.
Patient selection is obvious, with a statistically signiﬁcant
older population being treated with endovascular techniques
than those in the surgical cohort (almost a decade older).
This is similar to that of Jung et al10 whose mean age was
74.6 years. In addition, our group treated good surgical
candidates with surgery preferentially and those individuals
believed to be at higher risk of perioperative complications
with stent grafting. Despite improvements in stenting tech-
nology, our vascular surgeons remained conservative when
selecting patients to receive endovascular treatment. Patients
must have had comorbidities that place them at an elevated
risk for open surgical procedures and as well as possessed
vascular anatomy favorable for the endovascular approach.
The limitations of this study are obvious and in line with
other retrospective studies and include biased patient selec-
tion, change in physicians treating aneurysms (general and
cardiothoracic surgeons to almost exclusive fellowship trained
vascular surgeons), and limited data on follow-up. Patency
data and follow-up in those treated with endovascular
methods is shorter than that of bypass and exclusion patients.
Our group continues to support surgical reconstruc-
tion in good risk, younger patients by either the posterior
approach, or classical repair with bypass and exclusion.
Stent grafting can offer short-term and potentially midterm
arterial patency with a shorter hospitalization and lower
perioperative morbidity. Although signiﬁcant patient selec-
tion bias occurred, our results are promising in terms of
patency and 100% freedom from limb loss in our endovas-
cular-treated patients. In addition, if the endovascular
approach fails, patients still can undergo open surgical
interventions to prevent limb loss.
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